Newsfeeds - Spark Newswire

1 minute read

RedHill Biopharma Shares Surge New Treatment Patent For Its Late-Stage COVID-19 Candidate

Today, 9:58 PM

The United States Patent and Trademark Office (USPTO) granted a further method of use patent for RedHill Biopharma Ltd’s (NASDAQ:RDHL) COVID-19 treatment,…

RDHL

3 minute read

Why United Airlines Shares Are Trading Higher? Here Are 43 Stocks Moving In Wednesday’s Mid-Day Session

By Lisa Levin

Today, 9:58 PM

Gainers SenesTech, Inc. (NASDAQ: SNES) shares jumped 102.6% to $0.47 after declining over 3% on Tuesday. SenesTech, during August, posted a Q2 loss of $0.21 per share.

ABT

3 minute read

Crude Oil Rises 1.5%; Generac Holdings Shares Plummet

By Lisa Levin

Today, 9:58 PM

U.S. stocks traded mostly lower midway through trading, with the Dow Jones falling around 50 points on Wednesday.

GNRC

5 minute read

Options

Stocks That Hit 52-Week Lows On Tuesday

By Benzinga Insights

Today, 9:58 PM

During Tuesday's session, 78 companies made new 52-week lows.

ACHV

3 minute read

Why WISeKey International Is Trading Higher By Over 20%; Here Are 29 Stocks Moving Premarket

By Lisa Levin

Today, 9:58 PM

Gainers Statera Biopharma, Inc. (NASDAQ: STAB) rose 89.4% to $0.2655 in pre-market trading. Statera Biopharma was recently granted European patent number EP3206708 titled "Methods And Compositions For The Treatment Of Radiation-Related Disorders."

AREB

1 minute read

RedHill Biopharma Says Its Oral Broad-Acting Antivirals Inhibit Dominant Omicron Sub-Variant BA.5

By Vandana Singh

Today, 9:58 PM

RedHill Biopharma Ltd (NASDAQ:RDHL) announced study results showing in vitro efficacy against the currently dominant omicron COVID-19 sub-variant BA.5, by both…

RDHL

1 minute read

RedHill’s Oral Broad-Acting Antivirals, Opaganib and RHB-107, Inhibit Dominant Omicron Sub-Variant BA.5

By Benzinga Newsdesk

Today, 9:58 PM

Novel, oral, host-targeted, broad-acting antivirals, once-daily RHB-107 (upamostat) and twice-daily opaganib, demonstrated in vitro inhibition of the COVID-19-causing SARS-Cov-2 Omicron BA.5 sub-variant in testing

RDHL